The new Assisted Reproductive Technology (ART) regulations in India implements stricter guidelines to ensure the safety and ethical practice of ART. Here are the key points of the new regulations and their impact on cost and conception opportunities for Indian patients:

• The age limit for women undergoing ART has been set at 50 years. This may affect the affordability of treatment for older women.
• Ensuring that IVF clinics provide patients with full cost disclosure, including additional expenses such as medications, anesthesia, and lab tests, which may help patients compare prices.
• Limits have been imposed on the number of embryos that can be transferred to the womb during each cycle, with a maximum of two allowed for women under the age of 35. This could increase the cost for those who need additional cycles to conceive.
• Embryo freezing has been limited to up to five years, which may impact the chances of success for patients using frozen embryos beyond this limit
• The need of written consent from patients for several things which includes donors, surrogacy and also storing of gametes for future use, will help in transparent and ethical practices in the industry.
• The introduction of a national registry for all clinics operating ART will ensure greater accountability of the sector and more data to evaluate the impact of the industry on population health and human development.

Overall, the new regulations aim to ensure greater transparency and ethical standards in the ART sector, although the changes may increase the cost of treatment for some patients.